Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller
Via Investor's Business Daily
Exposures Product Safety
Tickers VRTX
Surf Up The Fun with a New Children’s Book that Celebrates the Magic of Building Sandcastles at the Jersey Shore
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025 - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
MDC Associates Adapts to Evolving Trends in the 510(k) Submission Process
Via Press Release Distribution Service
Exposures Product Safety
The Original Pulled Oxtail Meat™ Changes the Game: Pioneering Convenience, Culinary Innovation, & Community Engagement
Via PRLog
Exposures Product Safety
Tickers PEP
Revolutionary Sleep Again Pillow System Offers New Hope for Post-Surgery Recovery
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
Latest Poll: More Than One-Third of Moderate Voters Do Not Trust Federal Health Agencies
Via Get News
Exposures COVID-19 Product Safety
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox &amp; Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Submits FDA Application for 12-Lead ECG Synthesis Software
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT
Ozempic Receives FDA Approval To Treat Kidney Disease
Via Benzinga
Exposures Product Safety
Tickers NVO
Excel Mum Inspires Professionals to Work Smarter, Not Harder in Secrets of Self-Made Success Book
Via Get News
Topics Product Recall
Exposures Legal Product Safety
FDA Approves AstraZeneca, Daiichi Sankyo's Enhertu For Certain Type Of Breast Cancer Patients
Via Benzinga
Exposures Product Safety
Tickers AZN DSKYF DSNKY
$27 Million Funding; Coverage on Sanjay Gupta/CNN for Treatment of Suicidal Depression; Nasdaq Tier Uplisting: NRx Pharmaceuticals: Stock Symbol: NRXP
Via PRLog
Exposures Product Safety
Protheragen Introduces One-Stop Therapeutic Development Solutions to Accelerate Ophthalmic Drug Research
Via AB Newswire
Topics Supply Chain
Exposures Product Safety Supply Chain
BioMedNewsBreaks — Calidi Biotherapeutics Inc. (NYSE American: CLDI) Ends SEPA Agreement Following Successful Fundraising
Via Investor Brand Network
Exposures Product Safety
Tickers CLDI
Biogen Rises On FDA Nod for Alzheimer's Drug Dosing Regimen, But Sage Deal Fallout Irks Retail
Via Stocktwits
Exposures Product Safety
Tickers BIIB QLV SAGE XBI
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AVAI
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AVAI
APLT CLASS ACTION FILED: Kessler Topaz Meltzer &amp; Check, LLP Reminds Investors - a Securities Fraud Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT)
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors - a Securities Fraud Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT)
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
XRAY Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP Reminds DENTSPLY SIRONA Inc. (XRAY) Investors of Filing Deadline in Class Action Lawsuit
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
XRAY Deadline in 1 Day: Kessler Topaz Meltzer &amp; Check, LLP Reminds DENTSPLY SIRONA Inc. (XRAY) Investors of Filing Deadline in Class Action Lawsuit
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
Lead-Free Cinnamon: Druera Sets New Safety Standard
Via Prodigy
Topics Product Recall
Exposures Lead Legal Product Safety
Investors of Applied Therapeutics are Encouraged to Contact Kaplan Fox Before the February 18, 2025 Lead Plaintiff Deadline
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Investors of Applied Therapeutics are Encouraged to Contact Kaplan Fox Before the February 18, 2025 Lead Plaintiff Deadline
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Lead Plaintiff Deadline is February 18, 2025 - Investors of Applied Therapeutics are Encouraged to Contact Kaplan Fox
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Lead Plaintiff Deadline is February 18, 2025 - Investors of Applied Therapeutics are Encouraged to Contact Kaplan Fox
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Tesla Recalls Over 1.2 Million Vehicles In China Over Rear View Camera Malfunction, Power Steering Failure Concerns
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.